{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:54:49Z","timestamp":1771854889527,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Japan Orthopaedics and Traumatology Foundation, Inc.","award":["240"],"award-info":[{"award-number":["240"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedic Science"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jos.2019.02.009","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T14:17:02Z","timestamp":1553005022000},"page":"156-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical efficacy of risk-stratified prophylaxis with low-dose aspirin for the management of symptomatic venous thromboembolism after total hip arthroplasty"],"prefix":"10.1016","volume":"25","author":[{"given":"Masahiko","family":"Mihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunobu","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nariaki","family":"Nakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jos.2019.02.009_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/clc.4960240207","article-title":"Clinical characteristics of acute pulmonary thromboembolism in Japan: results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research","volume":"24","author":"Nakamura","year":"2001","journal-title":"Clin Cardiol"},{"issue":"3 suppl","key":"10.1016\/j.jos.2019.02.009_bib2","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of VTE in orthopedic surgery patients antithrombotic therapy and prevention of thrombosis, 7th ed: American College of chest Physicians evidence based clinical practice guidelines","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jos.2019.02.009_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.arth.2007.01.007","article-title":"Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis","volume":"22","author":"Burnett","year":"2007","journal-title":"J\u00a0Arthroplasty"},{"issue":"1","key":"10.1016\/j.jos.2019.02.009_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.arth.2012.06.001","article-title":"Complications related to therapeutic anticoagulation in total hip arthroplasty","volume":"28","author":"McDougall","year":"2013","journal-title":"J\u00a0Arthroplasty"},{"issue":"2 Suppl","key":"10.1016\/j.jos.2019.02.009_bib5","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest Physicians evidence based clinical practice guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"issue":"7329","key":"10.1016\/j.jos.2019.02.009_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"9678","key":"10.1016\/j.jos.2019.02.009_bib7","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"issue":"9212","key":"10.1016\/j.jos.2019.02.009_bib8","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin:pulmonary embolism prevention(PEP)trial","volume":"355","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jos.2019.02.009_bib9","first-page":"59","article-title":"Prevention of venous thromboembolism after total joint arthroplasty: aspirin is enough for most patients","volume":"44","author":"Dalury","year":"2015","journal-title":"Am J Orthop"},{"issue":"11","key":"10.1016\/j.jos.2019.02.009_bib10","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/jth.12728","article-title":"Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid","volume":"12","author":"Undas","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"10.1016\/j.jos.2019.02.009_bib11","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.arth.2015.06.045","article-title":"Thromboembolism prophylaxis in hip arthroplasty: routine and high-risk patients","volume":"30","author":"Nam","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"issue":"8","key":"10.1016\/j.jos.2019.02.009_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty","volume":"378","author":"Anderson","year":"2018","journal-title":"NEJM"},{"issue":"12","key":"10.1016\/j.jos.2019.02.009_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.5435\/00124635-201112000-00008","article-title":"AAOS clinical practice guideline: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty","volume":"19","author":"Jacobs","year":"2011","journal-title":"J\u00a0Am Acad Orthop Surg"},{"issue":"11","key":"10.1016\/j.jos.2019.02.009_bib14","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0002-9149(00)00766-9","article-title":"Risk of pulmonary embolism and\/or deep venous thrombosis in Asian-Americans","volume":"85","author":"Klatsky","year":"2000","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.jos.2019.02.009_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1302\/0301-620X.98B3.36511","article-title":"Aspirin for thromboprophylaxis after primary lower limb arthroplasty: early thromboembolic events and 90 day mortality in 11 459 patients","volume":"98-B","author":"Ogonda","year":"2016","journal-title":"J\u00a0Bone Joint Surg Br"},{"issue":"2","key":"10.1016\/j.jos.2019.02.009_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2106\/JBJS.16.00147","article-title":"Low-dose aspirin is effective chemoprophylaxis Against clinically important venous thromboembolism following total joint arthroplasty: a preliminary analysis","volume":"99","author":"Parvizi","year":"2017","journal-title":"J\u00a0Bone Joint Surg Am Vol"},{"issue":"5","key":"10.1016\/j.jos.2019.02.009_bib17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1302\/0301-620X.86B5.14763","article-title":"Mechanical prophylaxis of deep-vein thrombosis after total hip replacement a randomised clinical trial","volume":"86","author":"Pitto","year":"2004","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.jos.2019.02.009_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/BLO.0b013e31805b7681","article-title":"The 2007 ABJS Nicolas Andry Award: three decades of clinical, basic, and applied research on thromboembolic disease after THA: rationale and clinical results of a multimodal prophylaxis protocol","volume":"459","author":"Salvati","year":"2007","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.jos.2019.02.009_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4055\/cios.2017.9.1.37","article-title":"Intermittent pneumatic compression for the prevention of venous thromboembolism after total hip arthroplasty","volume":"9","author":"Kwak","year":"2017","journal-title":"Clin Orthop Surg"},{"issue":"8","key":"10.1016\/j.jos.2019.02.009_bib20","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.arth.2009.05.015","article-title":"Clinical efficacy of mechanical thromboprophylaxis without anticoagulant drugs for elective hip surgery in an Asian population","volume":"24","author":"Sugano","year":"2009","journal-title":"J\u00a0Arthroplasty"},{"issue":"12","key":"10.1016\/j.jos.2019.02.009_bib21","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1007\/s11999-011-1979-7","article-title":"Deep venous thrombosis and pulmonary embolism are uncommon in East Asian patients after total hip arthroplasty","volume":"469","author":"Kang","year":"2011","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"10.1016\/j.jos.2019.02.009_bib22","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11999-013-3358-z","article-title":"Symptomatic pulmonary embolus after joint arthropasty: stratification of risk factors","volume":"472","author":"Parvizi","year":"2014","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"10.1016\/j.jos.2019.02.009_bib23","first-page":"205","article-title":"Venous thromboembolism after total hip arthroplasty diagnosed by enhanced computed tomography:comparison of selective thromboprophylaxis and No thromboprophylaxis","volume":"69","author":"Okada","year":"2015","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.jos.2019.02.009_bib24","doi-asserted-by":"crossref","first-page":"23726","DOI":"10.1038\/srep23726","article-title":"Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials","volume":"6","author":"Ning","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jos.2019.02.009_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3810\/pgm.2013.07.2686","article-title":"A\u00a0Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention","volume":"125","author":"Revankar","year":"2013","journal-title":"Postgrad Med"},{"issue":"7","key":"10.1016\/j.jos.2019.02.009_bib26","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.arth.2015.02.009","article-title":"Rivaroxaban versus enoxaparin for venous thromboembolism prophylaxis after hip and knee arthroplasty","volume":"30","author":"Charters","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"issue":"9 Suppl","key":"10.1016\/j.jos.2019.02.009_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.arth.2015.04.048","article-title":"Direct costs of aspirin versus warfarin for venous thromboembolism prophylaxis after total knee or hip arthroplasty","volume":"30","author":"Gutowski","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"issue":"2","key":"10.1016\/j.jos.2019.02.009_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.arth.2014.08.018","article-title":"Cost-effective prophylaxis against venous thromboembolism after total joint arthroplasty: warfarin versus aspirin","volume":"30","author":"Tabatabaee","year":"2015","journal-title":"J\u00a0Arthroplasty"}],"container-title":["Journal of Orthopaedic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265819300582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265819300582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:29:57Z","timestamp":1760556597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0949265819300582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0949265819300582"],"URL":"https:\/\/doi.org\/10.1016\/j.jos.2019.02.009","relation":{},"ISSN":["0949-2658"],"issn-type":[{"value":"0949-2658","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical efficacy of risk-stratified prophylaxis with low-dose aspirin for the management of symptomatic venous thromboembolism after total hip arthroplasty","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedic Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jos.2019.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}